Specialties: Cardiovascular diseases
Clinical Interests:
Cardiomyopathy
Valvular heart disease
Coronary heart disease
Education
Sep, 2014- Jun, 2017: South Medical University, Guangzhou, Guangdong, China, Doctoral student of medicine in department of Cardiology
Sep, 2012- Jul,2014: South Medical University, Guangzhou, Guangdong, China, Master student of medicine in department of Cardiology
Sep, 2007– Jul, 2012: South Medical University, Guangzhou, Guangdong, China, Bachelor of South Medical University, China
Apr, 2014-May, 2015: Medical Center, Rush University, Chicago, US, Visiting Scholar of Cardiovascular Pharmacology
Jun, 2016-Sep, 2016: Harvard Medical School, Boston, US, Visiting Scholar of Developmental Biology
Awards and Honors
Outstanding Graduates of South Medical University. 2012
Outstanding Graduates of South Medical University. 2017
Outstanding young talents of Guangdong Provincial People's Hospital. 2019
Professional memberships
Professional member of European Society of Cardiology
Member of the American Heart Association
Member of American College of Cardiology
Professional member of HKSTENT
Member of HKCC
Member of SCC
PUBLICATIONS
1. Joint effects of uric acid and lymphocyte count on adverse outcomes in elderly patients with rheumatic heart disease undergoing valve replacement surgery. J Thorac Cardiovasc Surg. 2019 Aug;158(2):420-427.e1.
(Corresponding author)
2. Zinc ameliorates human aortic valve calcification through GPR39 mediated ERK1/2 signalling pathway. Cardiovasc Res. 2021 Feb 22;117(3):820-835.
(Co-First author)
3. FUNDC1 regulates mitochondrial dynamics at the ER-mitochondrial contact site under hypoxic conditions. EMBO J. 2016 May 4. pii: e201593102.
(Co-First author)
4. The cardiothoracic ratio: a neglected preoperative risk-stratified method for patients with rheumatic heart disease undergoing valve replacement surgery. Eur J Cardiothorac Surg. 2019 Mar 1;55(3):511-517.
(First author)
5. Utility of age, creatinine, and ejection fraction score in patients with type B aortic dissection undergoing thoracic endovascular aortic repair. Int J Cardiol. 2020 Mar 15;303:69-73.
(Corresponding author)
6. FUNDC1 is a novel mitochondrial-associated-membrane (MAM) protein required for hypoxia-induced mitochondrial fission and mitophagy. Autophagy. 2016 Jun 17:0.
(Corresponding author)
7. Magnesium Levels in Drinking Water and Coronary Heart Disease Mortality Risk: A Meta-Analysis. Jiang L, He P, Chen J, Liu Y, Liu D, Qin G, Tan N.Nutrients. 2016 Jan 2;8(1). pii: E5. doi: 10.3390/nu8010005
(First author)
8. The prognostic value of postoperative blood glucose in non-diabetic patients with rheumatic heart disease. BMC Cardiovasc Disord. 2019 Dec 17;19(1):297.
9. Thrombocytopenia as a Preoperative Risk Assessment Tool in Patients With Rheumatic Heart Disease Undergoing Valve Replacement Surgery. J Am Heart Assoc. 2017 Dec 4;6(12): e006988.
(Co-First author)
10. Value of pulmonary artery pressure in predicting in-hospital and one-year mortality after valve replacement surgery in middle-aged and aged patients with rheumatic mitral disease: an observational study. BMJ Open. 2017 May 10;7(5): e014316.
(First author)
